Once a niche pharmaceutical product used quietly in the background of autoimmune and malaria treatments, hydroxychloroquine has been thrust into the spotlight in recent years. From heated pandemic debates to renewed scientific interest, this decades-old drug is now part of a billion-dollar conversation. But what is really driving its resurgence—and is the world prepared for its next...